Abstract
In 2011, universal lipid screening was recommended for children aged 9 to 11 years; the impact of this recommendation on the lipid clinic setting is unknown. We examined the rate of primary and secondary dyslipidemia diagnoses in a lipid clinic before (2010-2011) and after (2012-2015) the guideline recommendation. We conducted a retrospective study of new clinic patients aged 0 to 20 years seen between April 2010 and April 2015. Chi-square testing was applied. The 345 subjects were 58% males; 48% ≥13 years; 56% Hispanic; and 59% obese. There was no difference in the rate of dyslipidemia diagnoses between periods (before: primary 23%, secondary 73%, no dyslipidemia 4% vs after: 22%, 72%, 6%, respectively; P =.616). There was no significant difference between periods in subject demographics for the total sample, but among those with primary dyslipidemia, pre- to post-guideline percentage of subjects with public insurance decreased (71% to 39%; P =.006). Additional strategies to increase identification of children with dyslipidemia are needed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 656-664 |
| Number of pages | 9 |
| Journal | Clinical pediatrics |
| Volume | 58 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2019 |
Fingerprint
Keywords
- cholesterol
- lipid clinic
- obesity
- pediatrics
- universal screening
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
Cite this
}
Characteristics of Children Referred to a Lipid Clinic Before and After the Universal Screening Guidelines. / Selvaraj, Kavitha; Olave-Pichon, Alicia; Benuck, Irwin; Ariza, Adolfo Javier; Binns, Helen.
In: Clinical pediatrics, Vol. 58, No. 6, 01.06.2019, p. 656-664.Research output: Contribution to journal › Article
TY - JOUR
T1 - Characteristics of Children Referred to a Lipid Clinic Before and After the Universal Screening Guidelines
AU - Selvaraj, Kavitha
AU - Olave-Pichon, Alicia
AU - Benuck, Irwin
AU - Ariza, Adolfo Javier
AU - Binns, Helen
PY - 2019/6/1
Y1 - 2019/6/1
N2 - In 2011, universal lipid screening was recommended for children aged 9 to 11 years; the impact of this recommendation on the lipid clinic setting is unknown. We examined the rate of primary and secondary dyslipidemia diagnoses in a lipid clinic before (2010-2011) and after (2012-2015) the guideline recommendation. We conducted a retrospective study of new clinic patients aged 0 to 20 years seen between April 2010 and April 2015. Chi-square testing was applied. The 345 subjects were 58% males; 48% ≥13 years; 56% Hispanic; and 59% obese. There was no difference in the rate of dyslipidemia diagnoses between periods (before: primary 23%, secondary 73%, no dyslipidemia 4% vs after: 22%, 72%, 6%, respectively; P =.616). There was no significant difference between periods in subject demographics for the total sample, but among those with primary dyslipidemia, pre- to post-guideline percentage of subjects with public insurance decreased (71% to 39%; P =.006). Additional strategies to increase identification of children with dyslipidemia are needed.
AB - In 2011, universal lipid screening was recommended for children aged 9 to 11 years; the impact of this recommendation on the lipid clinic setting is unknown. We examined the rate of primary and secondary dyslipidemia diagnoses in a lipid clinic before (2010-2011) and after (2012-2015) the guideline recommendation. We conducted a retrospective study of new clinic patients aged 0 to 20 years seen between April 2010 and April 2015. Chi-square testing was applied. The 345 subjects were 58% males; 48% ≥13 years; 56% Hispanic; and 59% obese. There was no difference in the rate of dyslipidemia diagnoses between periods (before: primary 23%, secondary 73%, no dyslipidemia 4% vs after: 22%, 72%, 6%, respectively; P =.616). There was no significant difference between periods in subject demographics for the total sample, but among those with primary dyslipidemia, pre- to post-guideline percentage of subjects with public insurance decreased (71% to 39%; P =.006). Additional strategies to increase identification of children with dyslipidemia are needed.
KW - cholesterol
KW - lipid clinic
KW - obesity
KW - pediatrics
KW - universal screening
UR - http://www.scopus.com/inward/record.url?scp=85062889557&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062889557&partnerID=8YFLogxK
U2 - 10.1177/0009922819834282
DO - 10.1177/0009922819834282
M3 - Article
C2 - 30854883
AN - SCOPUS:85062889557
VL - 58
SP - 656
EP - 664
JO - Clinical Pediatrics
JF - Clinical Pediatrics
SN - 0009-9228
IS - 6
ER -